{"nct_id":"NCT04949191","title":"The Purpose of the Study is to Continue to Provide Pemigatinib to Patients With Advanced Malignancies.","status":"TERMINATED","status_verified_date":"2024-08","start_date":"2021-07-08","start_date_type":"ACTUAL","primary_completion_date":"2024-04-11","primary_completion_date_type":"ACTUAL","completion_date":"2024-04-11","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["INCY"]}